Medivir has submitted an application to the European medical regulatory authorities for marketing authorization for its product Lipsovir®. The cream, a patented combination of acyclovir (an antiviral agent) and hydrocortisone (an anti-inflammatory agent) is used for preventing as well as treating cold sores. None of the already existing products on the market that are indicated for the condition have the effect that Lipsovir promises.